Background: Liver cirrhosis contributes to high liver-related mortality globally. Systemic
inflammation mediated by immune cells contributes to the progression of liver cirrhosis …

Objective This research aimed to explore the involvement of interleukins (IL)-IL-6, IL-17, IL-
21, and IL-23-in the evolution and diagnosis of non-alcoholic liver fibrosis and cirrhosis …

OBJECTIVE: To identify the roles of serum IL-18, IL-10, TNF-alpha and sIL-2R in the
pathogenesis of chronic hepatitis C and the effects of interferon on the mentioned serum …

Introduction: Recent studies indicate that mediators of inflammation (TNF-α),(IL-I β),(IL-6)
may exacerbate the effects of ammonia on the brain leading to more exacerbation of …

Background We aimed to investigate the expression and clinical significance of interleukin
17 (IL-17) in patients with primary biliary cirrhosis (PBC). Methods PBC patients (n= 127) …

The current study was designed to investigate the potential association of serum interleukin‐
10 and interleukin‐12 with HCV infection in chronic liver disease and to evaluate their …

More than 20 years after the discovery of the HCV, it is now well established that HCV is of
global importance affecting all countries, leading to a major global health problem that …

ABSTRACT Interleukin-17 (IL-17) is a proinflammatory factor produced by T helper 17 cells
and can induce a variety of chemokines which participate in the body's immunoregulation …

Interleukin‐10 (IL‐10) and interleukin‐6 (IL‐6) have been reported to be related to
hepatocellular carcinoma (HCC) prognosis. This study aimed to investigate the clinical …

Background/purpose of the study Chronic hepatitis C virus (HCV) infection is considered
one of the major health problems. About 170 million patients were infected with HCV …